Similar articles for PMID: 16052085

Year	Number of Results
1932	1
1994	1
1996	3
1997	2
1998	6
1999	5
2000	3
2001	10
2002	8
2003	8
2004	5
2005	5
2006	9
2007	9
2008	4
2009	5
2010	8
2011	4
2012	3
2013	3
2014	7
2015	9
2016	6
2017	4
2019	10
2020	6
2021	5
2023	1
2024	0

1

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis.

Yazdanpanah Y, Losina E, Anglaret X, Goldie SJ, Walensky RP, Weinstein MC, Toure S, Smith HE, Kaplan JE, Freedberg KA; Global AIDS Policy Model Investigators. Yazdanpanah Y, et al. AIDS. 2005 Aug 12;19(12):1299-308. doi: 10.1097/01.aids.0000180101.80888.c6. AIDS. 2005. PMID: 16052085 Clinical Trial.

2

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

Goldie SJ, Yazdanpanah Y, Losina E, Weinstein MC, Anglaret X, Walensky RP, Hsu HE, Kimmel A, Holmes C, Kaplan JE, Freedberg KA. Goldie SJ, et al. N Engl J Med. 2006 Sep 14;355(11):1141-53. doi: 10.1056/NEJMsa060247. N Engl J Med. 2006. PMID: 16971720 Free article.

3

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.

Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N'Dri-Yoman T, Salamon R. Anglaret X, et al. Lancet. 1999 May 1;353(9163):1463-8. doi: 10.1016/s0140-6736(98)07399-1. Lancet. 1999. PMID: 10232311 Clinical Trial.

4

Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.

Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C, Djomand G, Ackah A, Domoua K, Kadio A, Yapi A, Combe P, Tossou O, Roels TH, Lackritz EM, Coulibaly D, De Cock KM, Coulibaly IM, Greenberg AE. Wiktor SZ, et al. Lancet. 1999 May 1;353(9163):1469-75. doi: 10.1016/s0140-6736(99)03465-0. Lancet. 1999. PMID: 10232312 Clinical Trial.

5

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD. Freedberg KA, et al. JAMA. 1998 Jan 14;279(2):130-6. doi: 10.1001/jama.279.2.130. JAMA. 1998. PMID: 9440663

6

Effect of early chemoprophylaxis with co-trimoxazole on nutritional status evolution in HIV-1-infected adults in Abidjan, Côte d'Ivoire.

Castetbon K, Anglaret X, Attia A, Toure S, Dakoury-Dogbo N, Messou E, N'Dri-Yoman T, Dabis F, Salamon R; Cotrimo-CL Study Group. Castetbon K, et al. AIDS. 2001 May 4;15(7):869-76. doi: 10.1097/00002030-200105040-00007. AIDS. 2001. PMID: 11399959 Clinical Trial.

7

Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations.

Badri M, Ehrlich R, Wood R, Maartens G. Badri M, et al. AIDS. 2001 Jun 15;15(9):1143-8. doi: 10.1097/00002030-200106150-00009. AIDS. 2001. PMID: 11416716

8

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.

Ouattara EN, MacLean RL, Danel C, Borre ED, Gabillard D, Huang M, Moh R, Paltiel AD, Eholié SP, Walensky RP, Anglaret X, Freedberg KA. Ouattara EN, et al. PLoS One. 2019 Jun 27;14(6):e0219068. doi: 10.1371/journal.pone.0219068. eCollection 2019. PLoS One. 2019. PMID: 31247009 Free PMC article.

9

When to start antiretroviral therapy in resource-limited settings.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators. Walensky RP, et al. Ann Intern Med. 2009 Aug 4;151(3):157-66. doi: 10.7326/0003-4819-151-3-200908040-00138. Epub 2009 Jul 20. Ann Intern Med. 2009. PMID: 19620143 Free PMC article.

10

Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.

Pitter C, Kahn JG, Marseille E, Lule JR, McFarland DA, Ekwaru JP, Bunnell R, Coutinho A, Mermin J. Pitter C, et al. J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):336-43. doi: 10.1097/QAI.0b013e31802f12b5. J Acquir Immune Defic Syndr. 2007. PMID: 17327758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

146 results

Results by year